Senseneuro
Founded 2017 · 13 employees on LinkedIn · 1 known investors
Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.
Founders & leadership
Senseneuro was founded in 2017 by George "Chip" Shaw.
G"
George "Chip" ShawCo-founder
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2016 | $750K |
| National Science Foundation | Phase I | 2015 | $149.4K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Senseneuro do?
- Sense Neuro Diagnostics is developing non-invasive technology to rapidly detect stroke subtype and traumatic brain injury and to continuously monitor brain injury, producing a scan in 2.5 seconds that analyzes the entire cranial vault. Its investigational device, NeuroHawk, is intended for medical personnel and is pending FDA De Novo review.
- Who founded Senseneuro?
- Senseneuro was founded by George "Chip" Shaw in 2017.
- Who are Senseneuro's investors?
- Senseneuro's investors include Angel Physicians Fund.